SCHEMBL1754358

SCHEMBL1754358

Cc1cc(C(C)NC(=O)c2ccc3nc(C(C)(C)C(F)(F)F)ccc3c2)c(F)cc1CO

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.35
ROCK2 O75116 2/20 0.34
ROCK1 Q13464 2/20 0.34
PDE2A O00408 2/20 0.34
MTTP P55157 3/20 0.33
ACSS2 Q9NR19 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643883 0.86 PDE2A (0.33) PPARGROCK2ROCK1PDE2ATAS1R3
SCHEMBL1285056 0.83 TRPV1 (0.34) PDE2A
SCHEMBL2326235 0.81 ADORA2A (0.34) PDE2A
SCHEMBL2106773 0.80 MEN1 (0.39) PPARGPDE2ATAS1R3TAS1R1
SCHEMBL14377372 0.79 PDE2A (0.38) ROCK2ROCK1PDE2A
SCHEMBL1839932 0.79 BRPF1 (0.42) ROCK2MTTPACSS2TAS1R3TAS1R1
SCHEMBL2010061 0.79 BRPF1 (0.42) ROCK2MTTPACSS2TAS1R3TAS1R1
SCHEMBL1753951 0.78 TAS1R3 (0.41) ROCK2ROCK1TAS1R3TAS1R1
SCHEMBL1839109 0.78 ROCK2 (0.35) ROCK2ROCK1PDE2A
SCHEMBL1645220 0.78 PDE2A (0.36) PPARGPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158650-B2 Substituted phenylmethyl bicyclocarboxyamide compounds PFIZER INC. (US) 2012-04-17 US claimed
EP-2222631-B1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER (US) 2011-08-17 EP claimed
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER INC. 2010-04-08 US claimed
US-8158650-B2 Substituted phenylmethyl bicyclocarboxyamide compounds PFIZER INC. (US) 2012-04-17 US disclosed
US-8158650-B2 Substituted phenylmethyl bicyclocarboxyamide compounds PFIZER INC. (US) 2012-04-17 US disclosed
US-8158650-B2 Substituted phenylmethyl bicyclocarboxyamide compounds PFIZER INC. (US) 2012-04-17 US disclosed
EP-2222631-B1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER (US) 2011-08-17 EP disclosed
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER INC. 2010-04-08 US disclosed
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER INC. 2010-04-08 US disclosed
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER INC. 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS TRPV1, P2RY1, TRPV2 PPARG 669/4885ROCK2 4701/4885ROCK1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.